Wide-Moat Stocks: Companies Dominating Their Markets
Warren Buffett popularized the concept of an economic moat — a durable competitive advantage that protects a company’s profits and market share from rivals over time, much like the water surrounding a medieval castle protected its inhabitants. Morningstar later formalized the idea into a three-tier rating system: wide moat (advantages expected to last 20+ years), narrow moat (at least 10 years), and no moat.
Morningstar identifies five sources from which a moat can be derived:
- Network effect: The product becomes more valuable as more people use it — Visa, Mastercard, and Meta are classic examples.
- Intangible assets: Patents, brands, and regulatory licenses that block competitors — Coca-Cola’s brand power and Moody’s regulatory standing fall here.
- Switching costs: Customers face high costs or friction when changing providers — Microsoft’s enterprise software suite is a textbook case.
- Cost advantage: Structural cost efficiencies that competitors cannot replicate — Waste Management’s vertically integrated network of landfills, recycling centers, and exclusive municipal licenses is nearly impossible for new entrants to match.
- Efficient scale: Markets that naturally support only one or a few players — Union Pacific in railroads and ASML in extreme ultraviolet lithography, where it holds a near-monopoly on EUV systems essential for producing the most advanced semiconductor chips.
Wide-moat companies cluster heavily in technology, healthcare, consumer staples, financials, and industrials. Six of the Magnificent Seven — Nvidia, Meta Platforms, Apple, Amazon, Microsoft, and Alphabet — carry wide-moat designations. Beyond tech, names like LVMH, Novo Nordisk, and Ferrari maintain advantages rooted in heritage, patents, and exclusivity that competitors simply cannot replicate.
For those interested in a fund-based approach, the VanEck Morningstar Wide Moat ETF (MOAT) tracks the Morningstar Wide Moat Focus Index, which selects attractively priced companies with wide-moat ratings and rebalances quarterly across two staggered sub-portfolios of 40 stocks each.
Regulated brokerThe table below lists companies with unrivalled economic moats — businesses with dominant, hard-to-replicate market positions. All data including price and market cap are updated regularly.
| Stock | Price | Change % | Marketcap |
|---|---|---|---|
Gilead Sciences GILD | $130.73 | 3.34% | 162.31B |
Boeing BA | $238.34 | 0.50% | 188.24B |
GE HealthCare Technologies GEHC | $69.97 | 0.41% | 31.83B |
Walt Disney DIS | $99.95 | 1.80% | 173.56B |
Corteva CTVA | $79.85 | 1.97% | 53.28B |
Bristol-Myers Squibb BMY | $63.70 | 3.33% | 130.11B |
Alphabet (Google) GOOG | $361.06 | 3.81% | 4.42T |
Veeva Systems VEEV | $212.41 | 0.26% | 34.50B |
Altria Group MO | $68.07 | 0.00% | 113.66B |
TransUnion TRU | $79.34 | 2.91% | 15.20B |
U.S. Bancorp USB | $64.30 | 0.11% | 100.16B |
Agilent Technologies A | $141.09 | 1.36% | 39.85B |
NXP Semiconductors NXPI | $231.66 | 2.50% | 58.42B |
Allegion ALLE | $166.57 | 0.73% | 14.16B |
Kenvue KVUE | $19.40 | 0.79% | 37.24B |
Zimmer Biomet ZBH | $98.23 | 2.53% | 19.00B |
Pfizer PFE | $25.45 | 0.14% | 145.03B |
Bio-Rad Laboratories BIO | $342.51 | 2.89% | 9.17B |
Nike NKE | $41.73 | 0.47% | 61.90B |
International Flavors & Fragrances IFF | $87.12 | 7.70% | 22.24B |
United Parcel Service UPS | $107.53 | 1.45% | 91.40B |
Teradyne TER | $397.16 | 1.59% | 62.09B |
Estee Lauder EL | $87.46 | 0.56% | 31.64B |
Campbell Soup CPB | $22.83 | 0.31% | 6.81B |
Adobe ADBE | $256.71 | 0.30% | 102.04B |
Microchip Technology MCHP | $78.41 | 2.81% | 42.57B |
MarketAxess MKTX | $162.46 | 0.07% | 5.72B |
Huntington Ingalls Industries HII | $321.48 | 0.49% | 12.67B |
Brown Forman Inc BF-B | $28.48 | 0.04% | 13.07B |
Salesforce CRM | $191.43 | 0.23% | 156.78B |
Charles Schwab SCHW | $108.39 | 1.91% | 188.50B |
Emerson EMR | $164.47 | 3.54% | 92.12B |
Amazon AMZN | $272.58 | 1.74% | 2.94T |
Monolithic Power Systems MPWR | $1,344.63 | 0.72% | 66.06B |
Autodesk ADSK | $236.81 | 0.17% | 50.00B |
Air Products and Chemicals APD | $294.81 | 0.03% | 65.65B |
Amgen AMGN | $408.61 | 4.77% | 220.53B |
Otis Worldwide OTIS | $72.96 | 0.92% | 27.77B |
Thermo Fisher Scientific TMO | $577.08 | 2.18% | 213.37B |
Lam Research LRCX | $313.28 | 1.40% | 392.00B |
Masco MAS | $77.38 | 0.38% | 15.26B |
Mondelez MDLZ | $62.29 | 0.34% | 79.96B |
Honeywell HON | $248.12 | 0.27% | 78.64B |
Northrop Grumman NOC | $553.79 | 0.41% | 78.67B |
Equifax EFX | $175.13 | 1.13% | 20.57B |
IDEX IEX | $238.10 | 0.09% | 17.55B |
Microsoft MSFT | $488.62 | 0.85% | 3.63T |
Danaher DHR | $200.96 | 3.17% | 141.27B |
Merck MRK | $128.90 | 0.70% | 318.35B |
Constellation Brands STZ | $130.95 | 0.36% | 22.37B |
West Pharmaceutical WST | $350.77 | 0.58% | 24.69B |
Apple AAPL | $308.77 | 0.20% | 4.51T |
